| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |